World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
94
Citations
35727
World Ranking
809
National Ranking
509

Research.com Recognitions

  • 1988 - Fellow of the American Psychological Association (APA)

Overview

Irving Kirsch is affiliated with Harvard University in the United States. Their research spans significant areas within medicine and neuroscience, focusing particularly on cognitive neuroscience and psychiatry and mental health.

The primary topics of their work include:

  • Pain Management and Placebo Effect
  • Empathy and Medical Education
  • Treatment of Major Depression
  • Complementary and Alternative Medicine Studies
  • Psychosomatic Disorders and Their Treatments
  • Mental Health Research Topics
  • Pediatric Pain Management Techniques

Kirsch's recent published papers illustrate the depth and breadth of their work:

  • Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data, 2021, Nature Communications
  • Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports, 2020, BMJ evidence-based medicine
  • Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis, 2022, BMJ
  • Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial, 2021, Pain
  • What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus, 2020, Psychotherapy and Psychosomatics

Frequent co-authors collaborating with Kirsch include:

  • Ted J. Kaptchuk
  • Vitaly Napadow
  • John M. Kelley
  • Dan-Mikael Ellingsen
  • Sophie Juul

Publication venues where Kirsch has contributed multiple works include:

  • Pain
  • Psychosomatic Medicine
  • PLoS ONE
  • Systematic Reviews
  • bioRxiv (Cold Spring Harbor Laboratory)

Their research fields primarily cover:

  • Medicine
  • Neuroscience

Subfields of study show a focus on:

  • Cognitive Neuroscience
  • Psychiatry and Mental health
  • Pharmacology
  • Complementary and alternative medicine
  • Social Psychology

Irving Kirsch was recognized as a Fellow of the American Psychological Association (APA) in 1988.

Best Publications

  • Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

    Irving Kirsch;Brett J Deacon;Tania B Huedo-Medina;Alan Scoboria

  • Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

    Ted J Kaptchuk;John M Kelley;Lisa A Conboy;Roger B Davis

  • Response expectancy as a determinant of experience and behavior.

    Irving Kirsch

  • Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome

    Ted Jack Kaptchuk;Ted Jack Kaptchuk;Elizabeth Friedlander;John Michael Kelley;John Michael Kelley;M. Norma Sanchez

  • The Emperor's New Drugs: Exploding the Antidepressant Myth

    Irving Kirsch

  • Hypnosis as an adjunct to cognitive-behavioral psychotherapy: A meta-analysis.

    Irving Kirsch;Guy Montgomery;Guy Sapirstein

  • Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication

    Irving Kirsch;Guy Sapirstein

  • An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm

    Donald D Price;Leonard S Milling;Irving Kirsch;Ann Duff

  • Classical conditioning and the placebo effect

    Guy H Montgomery;Irving Kirsch

  • Sham device v inert pill: randomised controlled trial of two placebo treatments.

    Ted J Kaptchuk;William B Stason;Roger B Davis;Anna R T Legedza

  • Changing expectations: A key to effective psychotherapy.

    Irving Kirsch

  • How expectancies shape experience.

    Irving Kirsch

  • Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.

    Andrea W M Evers;Luana Colloca;Charlotte Blease;Marco Annoni

  • The Emperor's New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration

    Irving Kirsch;Thomas J. Moore;Alan Scoboria;Sarah S. Nicholls

  • Brain Activity Associated with Expectancy-Enhanced Placebo Analgesia as Measured by Functional Magnetic Resonance Imaging

    Jian Kong;Randy L. Gollub;Ilana S. Rosman;J. Megan Webb

  • Efficacy of antidepressants in adults

    Joanna Moncrieff;Irving Kirsch

  • Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks

    Slavenka Kam-Hansen;Moshe Jakubowski;John M. Kelley;John M. Kelley;John M. Kelley;Irving Kirsch;Irving Kirsch

  • Altered state of hypnosis: Changes in the theoretical landscape.

    Irving Kirsch;Steven Jay Lynn

  • Catastrophizing, depression and expectancies for pain and emotional distress

    Michael J.L. Sullivan;Wendy M. Rodgers;Irving Kirsch

  • Imaginative suggestibility and hypnotizability: an empirical analysis.

    Wayne Braffman;Irving Kirsch

  • Double-blind versus deceptive administration of a placebo.

    Irving Kirsch;Lynne J. Weixel

  • Hypnosis as an adjunct to cognitive)ehavioral psychotherapy: A meta-analysis.

    Irving Kirsch;Guy Montgomery;Guy Sapirstein

Frequent Co-Authors

Steven Jay Lynn
Steven Jay Lynn Binghamton University
Giuliana Mazzoni
Giuliana Mazzoni Sapienza University of Rome
Guy H. Montgomery
Guy H. Montgomery Icahn School of Medicine at Mount Sinai
Jens Gaab
Jens Gaab University of Basel
Blair T. Johnson
Blair T. Johnson University of Connecticut
Etzel Cardeña
Etzel Cardeña Lund University
Andrew L. Geers
Andrew L. Geers University of Toledo
Annalena Venneri
Annalena Venneri Brunel University London
Winfried Rief
Winfried Rief Philipp University of Marburg
Ben Colagiuri
Ben Colagiuri University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology opens the door to a variety of online programs and professional pathways in the USA. A popular direction for graduates is to become a Licensed Professional Counselor (LPC), a credential required to practice counseling independently in most states.

Each state sets its own specific education, examination, and supervised experience requirements for licensing. For example, you can learn how to get an lpc license in Virginia, including mandatory coursework and post-graduate supervision hours. Similarly, Washington licensed professional counselor requirements detail both academic prerequisites and national exam expectations.

States like West Virginia lpc licensure requirements and Wisconsin licensed professional counselor requirements also provide guidance on degree selection and the application process. Whether you are considering a master’s in clinical psychology, counseling, or a related field, becoming familiar with state-specific pathways is crucial to achieving your counseling career goals.

Best Scientists Citing Irving Kirsch

Trending Scientists

Recently Published Articles